Athersys Appoints Joseph Nolan to Its Board of Directors
Athersys, Inc. ATHX, a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today the appointment of Joseph "Joe" Nolan to its Board of Directors, effective January 4, 2023. Mr. Nolan is an …